Replies to post #3306 on Repros Therapeutics Inc (RPRX)

[zipjet]

MNTA

Copaxone has been the best of the MS drugs for many yearsij. As you suggest Tysabri may change that - it looks like it will be twice as effective as Copaxone and the Ifn class. Even Tysabri may yeald to Rituxan which on the surface looks about 50% more effective than Tysabri.

So I would not attribute much value to M356.

ij